Bipolar RFA of Painful Extra-spinal Bone Metastases (PERFACOOL)

  • STATUS
    Recruiting
  • End date
    Jul 25, 2024
  • participants needed
    65
  • sponsor
    University Hospital, Strasbourg, France
Updated on 4 October 2022

Summary

To evaluate the worst pain of cancer patients with painful extra-spinal bone metastases 1 month after bipolar radiofrequency ablation (RFA) performed with the Osteocool system.

Details
Condition Multi-metastatic Cancer
Treatment Percutaneous RFA
Clinical Study IdentifierNCT03738670
SponsorUniversity Hospital, Strasbourg, France
Last Modified on4 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

) Multi-metastatic cancer patients with at least one painful lytic bone metastasis
) Target lesion should correspond to a specific radiologic finding
) At least a moderate pain produce by target lesion (4 on a scale of 0 to 10 over the prior 24 hours with or without pain killers intake) assessed during selection evaluation
) Patients 18 years old
) Able to give written consent
) Life expectancy 1 months
) Patient affiliated to the National Health Insurance system

Exclusion Criteria

Radiation therapy on the target tumor terminated < 3 weeks before treatment
Any contra-indication for the procedure as stated by the radiologist in terms of tumor size, proximity to neural/vascular structures making the procedure at unacceptable risk
Any contra-indication for the procedure as stated by the radiologist related to patient's condition (e.g. cardiac pacemakers) making the procedure at unacceptable risk
Impaired haemostasis
Concurrent participation in other experimental studies that could affect endpoints of this study
Contraindication to any form of sedation/anaesthesia
Signs of local/systemic infection identified before procedure, in accordance with standard care
Sclerotic metastases
Adults under guardianship
Patients under judicial protection
Pregnant or breastfeeding woman
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note